Jyong Biotech (NASDAQ:MENS) Shares Gap Up – Here’s What Happened

Jyong Biotech Ltd. (NASDAQ:MENS) gapped up before the market opened on Monday . The stock had previously closed at $3.17, but opened at $3.45. Jyong Biotech shares last traded at $7.46, with a volume of 11,721,070 shares traded.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings restated a “sell (e+)” rating on shares of Jyong Biotech in a research note on Wednesday, October 8th. One analyst has rated the stock with a Sell rating, According to data from MarketBeat, the stock has a consensus rating of “Sell”.

Jyong Biotech Stock Performance

The company has a fifty day moving average price of $33.81.

Institutional Trading of Jyong Biotech

A hedge fund recently bought a new stake in Jyong Biotech stock. BNP Paribas Financial Markets purchased a new stake in Jyong Biotech Ltd. (NASDAQ:MENS) in the third quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor purchased 1,698 shares of the company’s stock, valued at approximately $67,000.

Jyong Biotech Company Profile

OUR MISSION We endeavor to develop and supply first-class innovative drugs to meet our customers’ health needs. We seek to be a valuable business organization that is held in high esteem by the public. We are a science-driven biotechnology company based in Taiwan and are committed to developing and commercializing innovative and differentiated new drugs (plant-derived) mainly specializing in the treatment of urinary system diseases, with an initial focus on the markets of the U.S., the EU, and Asia.